Xiaolan Ling
Impact in
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Surgery 1
- Esophageal and GI Pathology 1
-
- Cell death mechanisms and regulation 1
- Protein Degradation and Inhibitors 1
- Co-authors
- Dajun Yang (2 shared papers)Amro Aboukameel (1 shared paper)Shaomeng Wang (1 shared paper)Jack Wu (1 shared paper)Zaneta Nikolovska‐Coleska (1 shared paper)Ayad Al‐Katib (1 shared paper)Ramzi M. Mohammad (1 shared paper)Yuan Sun (1 shared paper)
- Journals
- Cancer Biology & Therapy (1 paper)Journal of Computer Assisted Learning (1 paper)Drug Discovery Today (1 paper)BMC Cancer (1 paper)
- Partner nations
- United StatesChinaMalta
In The Last Decade
Xiaolan Ling
4 papers receiving 41 citations
Peers
Comparison fields: 5 of 29
- Toxicology 3
- Genetics 8
- Molecular Biology 28
- Oncology 6
- Molecular Medicine 1
Countries citing papers authored by Xiaolan Ling
This map shows the geographic impact of Xiaolan Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Ling more than expected).
Fields of papers citing papers by Xiaolan Ling
This network shows the impact of papers produced by Xiaolan Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Ling. The network helps show where Xiaolan Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaolan Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 32 | |
| 2 | 2022 | 6 | |
| 3 | A novel pan inhibitor of Bcl-2 and Mcl-1 apogossypolone (ApoG2) with superior stability and improved activity against human leukemia and lymphoma cells. | 2007 | 3 |
| 4 | 2013 | 1 | |
| 5 | 2025 | 0 |
About Xiaolan Ling
Xiaolan Ling is a scholar working on Surgery, Molecular Biology, Genetics, Radiological and Ultrasound Technology and Clinical Psychology, having authored 5 papers that have together received 42 indexed citations. Recurring topics across this work include Research in Cotton Cultivation (1 paper), Cell death mechanisms and regulation (1 paper), Protein Degradation and Inhibitors (1 paper), Esophageal and GI Pathology (1 paper), Quality and Safety in Healthcare (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Family and Patient Care in Intensive Care Units (1 paper) and Telemedicine and Telehealth Implementation (1 paper). The work is most often cited by research in Toxicology (3 citations), Genetics (8 citations), Molecular Biology (28 citations), Oncology (6 citations) and Molecular Medicine (1 citation). Xiaolan Ling has collaborated with scholars based in United States, China and Malta. Frequent co-authors include Dajun Yang, Amro Aboukameel, Shaomeng Wang, Jack Wu, Zaneta Nikolovska‐Coleska, Ayad Al‐Katib, Ramzi M. Mohammad, Yuan Sun, Sanjeev Banerjee and Jianyong Chen. Their work appears in journals such as Cancer Biology & Therapy, Journal of Computer Assisted Learning, Drug Discovery Today and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.